Switch View
© PR Newswire
06.11.2025
ISIN: US1124631045
Brookdale Senior Living Inc
BKD
LISTED
NYSE
Brookdale Announces Third Quarter 2025 Results and Increases Adjusted EBITDA Annual Guidance
News Preview
NASHVILLE, Tenn., Nov. 6, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or the "Company") announced results for the quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
Humana Inc. to Present at 2025 Wolfe Research Healthcare Conference
News Preview
Humana Inc. (NYSE: HUM) announced today that Celeste Mellet, Chief Financial Officer, will make a presentation to investors at the Wolfe Research Healthcare Conference on Wednesday, November 19, 2025, at 8:40 a.m. Eastern time.
A live audio webcast of the presentation will be available via Humana’s Investor Relations page at https://humana.gcs-we...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: CA25253X2077
DiaMedica Therapeutics, Inc.
DMAC
LISTED
NASDAQ
DiaMedica Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update November 13, 2025
News Preview
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia and acute ischemic stroke, announced today that its third quarter 2025 financial results will be released after the markets close on Wednesday, November 12th. DiaMedica will host a live conference call on T...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
06.11.2025
ISIN: US30050B1017
Evolent Health Inc
EVH
LISTED
NYSE
Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden
News Preview
WASHINGTON, Nov. 6, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, and American Oncology Network (AON), one of the nation's fastest-growing community oncology networks, today announced a new model enabling high-quali...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
06.11.2025
ISIN: US30050B1017
Evolent Health Inc
EVH
LISTED
NYSE
Evolent Announces Third Quarter 2025 Results
News Preview
Q3 2025 financial results ahead of expectations.
Announces more than $500 million in newly-contracted annualized revenue to launch in 2026.
Expands leadership team to support accelerating growth.
WASHINGTON, Nov. 6, 2025 /PRNe...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US88025U1097
10X Genomics Inc
TXG
LISTED
NASDAQ
10x Genomics Reports Third Quarter 2025 Financial Results
News Preview
PLEASANTON, Calif., Nov. 6, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US03763A2078
Astrana Health Inc
AMEH
LISTED
NASDAQ
Astrana Health, Inc. Reports Third Quarter 2025 Results
News Preview
Company to Host Conference Call on Thursday, November 6, 2025, at 2:30 p.m. PT/5:30 p.m. ET
Reports total revenue of $956.0 million, up 100% year-over-year, and at the higher end of guidance...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly announces two new Executive Committee members and expansion of leadership roles to prepare for next wave of growth
News Preview
INDIANAPOLIS, Nov. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the appointment of two new Executive Committee members and the expansion of other senior leaders' roles designed to accelerate one of the industry's most ambitious pipelines, generate new portfolio opportunities, and stre...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US83444M1018
Solventum Corporation
SOLV
LISTED
NYSE
Solventum Reports Third Quarter 2025 Financial Results
News Preview
Reported sales increased 0.7%; organic sales increased 2.7%
Expects full year organic sales growth to be at the high end of +2.0% to +3.0% range
Increases full year adjusted earnings per share outlook to $5.98 to $6.08
Announces 4-year 'Transform for the Futur...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US2289031005
Artivion Inc
AORT
LISTED
NYSE
Artivion Reports Third Quarter 2025 Financial Results
News Preview
Third Quarter Highlights:
Achieved revenue of $113.4 million in the third quarter of 2025 versus $95.8 million in the third quarter of 2024, an increase of 18% on a GAAP basis and 16% on a non-GAAP constant currency basis
Net income was $6.5 m...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US89532M1018
Trevi Therapeutics Inc
TRVI
LISTED
NASDAQ
Trevi Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 13, 2025
News Preview
Conference call and webcast to be held at 4:30 p.m. ET
NEW HAVEN, Conn., Nov. 6, 2025 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: IE00B91XRN20
Prothena Corporation PLC
PRTA
LISTED
NASDAQ
Prothena Reports Third Quarter 2025 Financial Results and Business Highlights
News Preview
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today reported financial results for the third quarter and first nine months of 2025 and provided business highlights.
“We are pleased with the advancement of our late...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
06.11.2025
ISIN: US81728J1097
Sensus Healthcare, Inc.
SRTS
LISTED
NASDAQ
Sensus Healthcare Reports Third Quarter 2025 Financial Results
News Preview
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces financial results for the three and nine months ended September 30, 2025.
Highlights of the third quarter of 2025 and subseq...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US2053061030
TruBridge Inc
TBRG
LISTED
NASDAQ
TruBridge Announces Third Quarter 2025 Results
News Preview
TruBridge, Inc. (NASDAQ: TBRG), a leading provider of revenue cycle management and healthcare technology solutions for rural and community healthcare organizations, today announced financial results for the third quarter and nine months ended September 30, 2025.
Third Quarter 2025 Highlights
All comparisons are to the quarter ended September 30,...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US8753722037
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
Tandem Diabetes Care Announces Third Quarter 2025 Financial Results
News Preview
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2025 and reaffirmed full year 2025 guidance.
Third Quarter 2025 and Recent Highlights
Achieved record third quarter sales both in the United States (U.S.) and internationa...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US74587B1017
Pulse Biosciences Inc
PLSE
LISTED
NASDAQ
Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
News Preview
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced plans to participate in two upcoming investor conferences.
Stifel 2025 Healthcare Conference, in New York, New York. Management is scheduled to presen...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US6323071042
Natera Inc
NTRA
LISTED
NASDAQ
Natera Reports Third Quarter 2025 Financial Results
News Preview
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today reported its financial results for the third quarter ended September 30, 2025.
Recent Financial Highlights
Generated total revenues of $592.2 million in the third quarter of 2025, compared to $439.8 million in the third quarter of 2024, an increase of 34...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US74587V1070
Puma Biotechnology Inc
PBYI
LISTED
NASDAQ
Puma Biotechnology Reports Third Quarter 2025 Financial Results
News Preview
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the third quarter ended September 30, 2025. Unless otherwise stated, all comparisons are for the third quarter of 2025 compared to the third quarter of 2024.
Product revenue, net consists entirely of sales revenue from NERLYNX®, Puma’s first comm...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US45257U1088
Immunome Inc
IMNM
LISTED
NASDAQ
Immunome Reports Third Quarter 2025 Financial Results and Provides Business Update
News Preview
Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced financial results for the quarter ended September 30, 2025, and provided a business update.
“Immunome’s pipeline continues to advance,” said Clay B. Siegall, Ph.D., President and Chief Executive...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: CA00288U1066
Abcellera Biologics Inc
ABCL
LISTED
NASDAQ
AbCellera Reports Q3 2025 Business Results
News Preview
AbCellera (Nasdaq: ABCL) today announced financial results for the third quarter of 2025. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.
“AbCellera successfully delivered on two corporate priorities this quarter by starting activities at our new clinical manufacturing facility and substant...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US30161Q1040
Exelixis Inc
EXEL
LISTED
NASDAQ
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in November
News Preview
Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will participate in fireside chats at the following investor conferences in November:
Guggenheim 2nd Annual Healthcare Innovation Conference: Exelixis is scheduled to present at 10:30 a.m. ET / 7:30 a.m. PT on Monday, November 10 in Boston.
Stifel 2025 Healthcare Conference:...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US09062W2044
BioLife Solutions Inc
BLFS
LISTED
NASDAQ
BioLife Solutions Reports Third Quarter 2025 Financial Results
News Preview
Cell Processing revenue of
$25.4 million, up 33% over Q3 2024
GAAP gross margin of
62%
and non-GAAP adjusted gross margin of
64%
GAAP...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US26622P1075
Doximity Inc
DOCS
LISTED
NYSE
Doximity Announces Fiscal 2026 Second Quarter Financial Results
News Preview
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 second quarter ended September 30, 2025.
“Our platform continues to grow with new AI tools to save physicians’ time,” said Jeff Tangney, co-founder and CEO of Doximity. “In Q2, a record 650,000 prescribers used our...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: CA60255C8850
Mind Medicine (MindMed) Inc
MNMD
LISTED
NASDAQ
MindMed Reports Q3 2025 Financial Results and Business Updates
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today reported financial results for the third quarter ended September 30, 2025 and provided business updates.
“2025 continues to be a year of strong execut...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US1570851014
Cerus Corp
CERS
LISTED
NASDAQ
Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance
News Preview
Cerus Corporation (Nasdaq: CERS) announced today financial results for the third quarter ended September 30, 2025, and provided a business update.
“We continue to make great strides in improving the safety and availability of transfused blood components around the globe and the record quarterly product revenue results reflect that progress. Produ...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US53566P1093
Lineage Cell Therapeutics Inc.
LCTX
LISTED
TLV
Lineage Cell Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
News Preview
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell therapies for serious medical conditions, today reported its third quarter 2025 financial and operating results and will host a conference call today at 4:30 p.m. Eastern Time to discuss these...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US47103J1051
Janux Therapeutics Inc
JANX
LISTED
NASDAQ
Janux Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights
News Preview
Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technologies to its Tumor Activated T Cell Engager (TRACTr), Tumor Activated Immunomodulator (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms, today reported fi...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US56600D1072
Maravai LifeSciences Holdings Inc
MRVI
LISTED
NASDAQ
Maravai LifeSciences Reports Third Quarter 2025 Financial Results
News Preview
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2025, together with other business updates.
Quarterly Results:
Revenue of $41.6 million, Net loss of $(45.1) milli...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US24661P8077
Delcath Systems, Inc.
DCTH
LISTED
NASDAQ
Delcath Systems to Participate in Upcoming Investor Conferences
News Preview
Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that management will be attending the following investor conferences:
Craig-Hallum Alpha Select Conference on Tuesday, November 18, 2025, in New York, NY
Canaccord Genuity MedTech, Di...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: IE00B56GVS15
Alkermes Plc
ALKS
LISTED
NASDAQ
Alkermes to Participate in Two Upcoming Investor Conferences
News Preview
DUBLIN, Nov. 6, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in two upcoming investor conferences.
Stifel 2025 Healthcare Conference
Date/Time: Thursday, Nov. 13, 2025 at 2:40 p.m. ET (7:40 p.m. GMT)...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: IE00B56GVS15
Alkermes Plc
ALKS
LISTED
NASDAQ
Alkermes to Participate in Two Upcoming Investor Conferences
News Preview
DUBLIN, Nov. 6, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in two upcoming investor conferences.
Stifel 2025 Healthcare Conference
Date/Time: Thursday, Nov. 13, 2025 at 2:40 p.m. ET (7:40 p.m. GMT)...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US23285D1090
Cytek Biosciences Inc
CTKB
LISTED
NASDAQ
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
News Preview
The Cytek® Muse® Micro cell analyzer has been named Drug Discovery Solution of the Year in the 2025 BioTech Breakthrough Awards....
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US77313F1066
Rocket Pharmaceuticals Inc
RCKT
LISTED
NASDAQ
Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
News Preview
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today reported financial and recent operational results for the third quarter ending September 30, 2025.
“During the third quarter, we maintained disciplin...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US09077V1008
BIOAGE Labs Inc
BIOA
LISTED
NASDAQ
BioAge Labs Reports Third Quarter 2025 Financial Results and Provides Business Updates
News Preview
First participant dosed in Phase 1 trial of BGE-102, oral CNS-penetrant NLRP3 inhibitor, with initial SAD data expected by year-end...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US83601L1026
Sotera Health Co
SHC
LISTED
NASDAQ
Sotera Health Announces Secondary Offering of Common Stock
News Preview
Announcement of launch of secondary stock offering...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US7530181004
Rani Therapeutics Holdings, Inc.
RANI
LISTED
NASDAQ
Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update
News Preview
– Announced up to $1.085 billion collaboration with Chugai Pharmaceutical Co. for multiple high-value therapeutics –...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US5560991094
MacroGenics Inc
MGNX
LISTED
NASDAQ
MacroGenics to Participate in the Stifel 2025 Healthcare Conference
News Preview
ROCKVILLE, MD, Nov. 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that Eric Risser, President and CEO of MacroGenics, will participate in a fireside chat at the Stifel 2025 Healthcare Conference on...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US8693671021
Sutro Biopharma Inc
STRO
LISTED
NASDAQ
Sutro Biopharma Reports Third Quarter 2025 Financial Results and Business Highlights
News Preview
– Company announces U.S. FDA clearance of Investigational New Drug (IND) application for STRO-004, its potential best-in-class Tissue Factor ADC; Expects to dose first patient before year-end –...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US82024L1035
Shattuck Labs Inc
STTK
LISTED
NASDAQ
Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business Highlights
News Preview
–First participants dosed in Phase 1 clinical trial of SL-325 in healthy volunteers –...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US87918A1051
Teladoc Health Inc
TDOC
LISTED
NYSE
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
News Preview
NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US29664W1053
Esperion Therapeutics Inc
ESPR
LISTED
NASDAQ
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
News Preview
ANN ARBOR, Mich., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on November 4, 2025, the Company granted 23 new employees 77,650 restricted stock units (RSUs) under Esperion’s 2017 Inducement Equity Incentive Plan....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US1920051067
Codexis Inc
CDXS
LISTED
NASDAQ
Codexis Reports Third Quarter 2025 Financial Results
News Preview
Announces signing of $37.8m Supply Assurance Agreement with Merck...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US3795772082
Globus Medical Inc
GMED
LISTED
NYSE
Globus Medical Reports Third Quarter 2025 Results
News Preview
AUDUBON, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US0017441017
AMN Healthcare Services Inc
AMN
LISTED
NYSE
AMN Healthcare Announces Third Quarter 2025 Results
News Preview
Quarterly revenue of $634 million and adjusted EBITDA of $58 million; GAAP income of $0.76/share and adjusted EPS of $0.39...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US15687V1098
Certara Inc
CERT
LISTED
NASDAQ
Certara Reports Third Quarter 2025 Financial Results
News Preview
Updates Full Year 2025 Financial Guidance Updates Full Year 2025 Financial Guidance...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US23284F1057
CytomX Therapeutics Inc
CTMX
LISTED
NASDAQ
CytomX Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
News Preview
- CX-2051 Phase 1 data update on track for Q1 2026 -...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US1717571079
Cidara Therapeutics, Inc.
CDTX
LISTED
NASDAQ
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
News Preview
SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company or Cidara), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today reported financial results for the third quarter ended September 30, 2025, and provided recent business updates....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US81578P1066
Seer Inc
SEER
LISTED
NASDAQ
Seer Reports Third Quarter 2025 Financial Results
News Preview
REDWOOD CITY, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the third quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US7291391057
Pliant Therapeutics Inc
PLRX
LISTED
NASDAQ
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
News Preview
Oncology program advancing with data expected in the fourth quarter 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US14147L1089
Cardiff Oncology Inc
CRDF
LISTED
NASDAQ
Cardiff Oncology Reports Third Quarter 2025 Results and Provides Business Update
News Preview
– Announced positive data from the ongoing Phase 2 CRDF-004 trial evaluating onvansertib + standard of care for the treatment of first-line RAS-mutated metastatic colorectal cancer –...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US0144421072
Alector Inc
ALEC
LISTED
NASDAQ
Alector Reports Third Quarter 2025 Financial Results and Provides Business Update
News Preview
Selected lead candidates AL137 for the company’s Alector Brain Carrier (ABC)-enabled anti-amyloid beta antibody in Alzheimer's disease, and AL050 for its ABC-enabled GCase enzyme replacement therapy in Parkinson’s disease; both advancing toward IND-enabling studies...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US23285D1090
Cytek Biosciences Inc
CTKB
LISTED
NASDAQ
Cytek Biosciences to Participate in Upcoming Investor Conferences
News Preview
FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences....
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Meridian Health Plan of Illinois and Centene Foundation Give $300,000 to Food Pantries to Help Tackle Food Insecurity in Illinois
News Preview
Donations strengthen community food resources for families struggling to access healthy food
CHICAGO, Nov. 6, 2025 /PRNewswire/ -- Meridian Health Plan of Illinois, Inc. (Meridian) and Centene Foundation, the philanthropic arm of Centene Corporation (NYSE: CNC),...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US5324571083
Eli Lilly and Co
LLY
LISTED
NYSE
Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans
News Preview
Medicare beneficiaries with obesity or overweight will have access to
Zepbound and orforglipron, if approved, at $50 a month
INDIANAPOLIS, Nov. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced an agreement with the...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Superior HealthPlan and Centene Foundation Make $400,000 Investment to Help Tackle Food Insecurity in Texas
News Preview
Investment strengthens community food resources for families struggling to access healthy meals
AUSTIN, Texas, Nov. 6, 2025 /PRNewswire/ -- Superior HealthPlan and Centene Foundation, the philanthropic arm of Centene Corporation (NYSE: CNC), today announced a st...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: US19249H1032
Coherus Oncology Inc
CHRS
LISTED
NASDAQ
Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer
News Preview
– Responsible for Corporate Development, Investor Relations, Government Affairs –...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Avantor, Inc. (AVTR) Shareholders To Inquire About Securities Fraud Class Action
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) common stock between March 5, 2024 and October 28, 2025, inclusive (the “Class Peri...
Themefolio
Profiler
Peergroup
© BusinessWire
06.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Baxter International
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX).
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of...
Themefolio
Profiler
Peergroup
© Newsfile
06.11.2025
ISIN: CA50206C1005
LIR Life Sciences Corp.
SKNY
LISTED
CSE
CSE Bulletin: Fundamental Change - Blackbird Critical Metals Corp./LIR Life Sciences Corp.
News Preview
Toronto, Ontario--(Newsfile Corp. - Le 6 novembre/November 2025) - The common shares of LIR Life Sciences Corp. (SKNY), previously listed as Blackbird Critical Metals Corp. (BBRD), have been approved for listing on the CSE. Listing and disclosure documents will be available at www.thecse.com on the trading date. LIR Life...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost
News Preview
Novo Nordisk has agreed with the U.S. Administration to lower drug prices beginning in 2026 and expand patient access and affordability for semaglutide ......
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
